Production-area image illustrating manufacturing activity. It does not depict a U.S. customer project, an audit or an official approval.

For a Chinese supplement manufacturer serving a U.S. project, the question is not only whether a product can be made. Customers also need ingredient specifications, manufacturing information and records that support their own supplier-assessment process. This article describes the company's service approach; it does not assert FDA certification, FDA approval, or that SPARDER has assumed a U.S. importer's legal duties.

Know whose obligation FSVP is

The U.S. Food and Drug Administration explains that the Foreign Supplier Verification Programs (FSVP) rule places duties on covered U.S. importers, with provisions that vary by product and circumstance. A foreign manufacturer can provide relevant information and cooperate with verification activities, but it cannot replace the importer's own assessment and records. See the FDA's FSVP key requirements.

What supplier information may help?

Depending on the product and project, customers may ask for ingredient identity and specifications, formula and packaging versions, manufacturing and quality records, change control, deviation handling and clear responses to audit questions. The exact package should be agreed against the actual product, the responsible importer and applicable U.S. requirements. A checklist cannot by itself establish compliance.

Start the discussion before production

SPARDER's approach is to clarify the target market, product category, proposed formula, ingredient specifications, dosage form, packaging, label information and expected documentation early in the project. This can reveal missing information before sampling or production and make later changes easier to trace.

Manufacturing practice and supplier verification are related but distinct

FDA guidance describes 21 CFR Part 111 as current good manufacturing practice for dietary supplements. FSVP concerns how a covered importer evaluates and verifies its foreign supplier, subject to the provisions applicable to the specific imported item. A private audit or a supplier's internal review should not be presented as an FDA approval, a universal certification, or a finding that every product is eligible for the U.S. market.

From documentation to project execution

Different dosage forms require different process and quality considerations. For an OEM/ODM customer, the practical value lies in clear specifications, controlled versions, accessible records and timely communication when a change occurs. SPARDER says it is continuing to strengthen these practices across R&D, production, quality and customer service.

Project-specific regulatory status, labelling and supplier verification must be assessed by the responsible parties against the actual product and current requirements.